The Real Dangers of Insurance Companies Denying Medical Treatment for Immunodeficient Patients

Health insurance is a business. Often times, their decisions are driven by loopholes, finances and bureaucracy. In a recent article, CNN reports about the effects that health insurance denials have on a class of patients suffering from immunodeficiency. These patients require this treatment to enable them to lead normal lives. According to the CNN Article, “35,000 to 50,000 people in the U.S. are estimated to be dependent on medications to treat primary immunodeficiency diseases — about 300 rare conditions in which the immune system doesn’t function properly, or at all. The medication, known as immunoglobulin replacement therapy, replaces antibodies that the body doesn’t make. It can cost tens of thousands of dollars each year.”

The reality is that this medicine is expensive and insurance companies have an incentive to deny treatment by making patients and health care providers dodge as many roadblocks and jump through as many hoops as possible. Unfortunately, litigation for breach of contract can become necessary to hold certain health insurance companies responsible for unreasonable denials. A potential offshoot of this problem is that health care providers may not recommend or request necessary treatment due to fears of health insurance approval. This would be potentially considered medical malpractice but it is an unfortunate reality.

If you need medical malpractice representation, it is important to retain a skilled attorney. Queller, Fisher, Washor, Fuchs & Kool, L.L.P., was formed by the merger of two major New York medical malpractice and personal injury law firms. We have the experience to handle any case, no matter how complex. For a free consultation, please call our New York medical malpractice attorneys at 212-406-1700 or contact us on-line